✦ LIBER ✦

Subgroup and cost-benefit analysis of the Finnish multicentre trial of clodronate in multiple myeloma

✍ Scribed by Markku Laakso; Reino Lahtinen; Pekka Virkkunen; Inkeri Elomaa

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised, placebo-controlled multicent

✍ Lahtinen, Reino; Laakso, Markku; Palva, Ilmari; Elomaa, Inkeri; Virkkunen, Pekka 📂 Article 📅 1992 🏛 The Lancet 🌐 English ⚖ 550 KB

Outcome of patients with diabetes and un

✍ Juan C. García-Rubira; Jose M. Cruz; Victor López; Leandro Plaza; Juan C. Navas 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 282 KB

The potential benefits of participating

✍ Paul G. Richardson; Jacob P. Laubach; Robert L. Schlossman; Irene M. Ghobrial; K 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

PCN65 A COST-EFFECTIVENESS ANALYSIS OF T

✍ KK Lee; VW Lee; KC Kuok 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

Dementia severity and the magnitude of c

✍ Kurtulus Sahin; Albrecht Stoeffler; Petra Furtuna; Doris Rosenwald; Hans-Joerg M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Neuro-radiological findings and the magn

✍ G. Wilcock; A. Stoeffler; K. Sahin; H.J. Moebius 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 154 KB